Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a backend/CMS update that does not alter the study details shown on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, marking a new release build. This change does not alter the study content or user-facing functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a new maintenance update. This change reflects versioning but does not alter the page content or user-facing features.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page. This indicates the study document has been updated to a newer version without changing the displayed study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page no longer shows the Study Protocol and Statistical Analysis Plan and several associated study-document details, removing the linked documents, contributor names, and institution references that help explain the study design and provenance.SummaryDifference16%

- Check73 days agoChange DetectedRecruitment status updated to indicate no participants are being sought; navigation and metadata were updated, including replacing 'Intervention / Treatment' with 'Intervention/Treatment', adding a new 'Revision: v3.6.0' label, and introducing new help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.5%

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.